Gene hunt for rare cancers aims to unlock new treatments
NCT ID NCT02688517
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This research study is looking at the genetic makeup of tumors from 1,100 people with rare or hard-to-treat cancers. By analyzing blood and tissue samples, scientists hope to find specific gene changes that could lead to better diagnosis and more effective treatments. The goal is to understand which genetic mutations are most common in these cancers and how they might be targeted with existing or new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bayshore Community Hospital
COMPLETEDHolmdel, New Jersey, 07733, United States
-
Jersey Shore Medical Center
COMPLETEDNeptune City, New Jersey, 07753, United States
-
Morristown Medical Center
COMPLETEDMorristown, New Jersey, 07960, United States
-
Ocean Medical Center
COMPLETEDBrick, New Jersey, 08724, United States
-
Overlook Hospital
COMPLETEDSummit, New Jersey, 07902, United States
-
RWJBarnabas Health - Jersey City Medical Center, Jersey City
RECRUITINGJersey City, New Jersey, 07302, United States
-
Riverview Medical Center
ACTIVE_NOT_RECRUITINGRed Bank, New Jersey, 07701, United States
-
Riverview Medical Center/Booker Cancer Center
COMPLETEDRed Bank, New Jersey, 07701, United States
-
Rutgers Cancer Institute of New Jersey
RECRUITINGNew Brunswick, New Jersey, 08903, United States
-
Southern Ocean County Medical Center
COMPLETEDManahawkin, New Jersey, 08050, United States
-
University of Wisconsin Hospital and Clinics
WITHDRAWNMadison, Wisconsin, 53792, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may one day personalize drug dosing after stem cell transplants
- New imaging agent aims to sharpen cancer detection
- Could a daily pill tame rare cancers in teens? new trial investigates
- Could your genes hold the key to cancer risk? scientists investigate families
- Cancer patients get help planning families in new study
- New hope for kids with resistant cancers: targeted drug enters trial